|
[1] YANG J,LI H,ZHENG RS,et al. Incidence and mortality of pancreatic cancer in China,2014[J]. China Cancer,2018,27(6):420-425.(in Chinese)杨军，李贺，郑荣寿，等．2014年中国胰腺癌发病与死亡分析[J]．中国肿瘤，2018,27(6):420-425.
|
|
[2] SIEGEL RL,MILLER KD,JEMAL A. Cancer statistics,2015[J]. CA Cancer J Clin,2015,65:5-29.
|
|
[3] JEMAL A,SIEGEL R,XU J,et al. Cancer statistics,2010[J]. CA Cancer J Clin,2010,60(5):277-300.
|
|
[4] MAJUMDER S,CHARI ST,AHLQUIST DA. Molecular detection of pancreatic neoplasia:Current status and future promise[J]. World J Gastroenterol,2015,21:11387-11395.
|
|
[5] DAS PM,SINGAL R. DNA methylation and cancer[J]. J Clin Oncol,2004,22:4632-4642.
|
|
[6] WU B,SHEN YY,CHEN XJ,et al. Value of endoscopic ultrasonography in diagnosis of pancreatic space-occupying diseases[J]. J Clin Hepatol,2018,34(8):1723-1727.(in Chinese)吴斌，沈亦钰，陈徐艰，等．超声内镜在胰腺占位性疾病诊断中的价值[J]．临床肝胆病杂志，2018,34(8):1723-1727.
|
|
[7] YI JM,GUZZETTA AA,BAILEY VJ,et al. Novel methylation biomarker panel for the early detection of pancreatic cancer[J]. Clin Cancer Res,2013,19(23):6544-6555.
|
|
[8] FUKUSHIMA N,SATO N,UEKI T,et al. Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma[J]. Am J Pathol,2002,160(5):1573-1581.
|
|
[9] SATO N,FUKUSHIMA N,HRUBAN RH,et al. CpG island methylation profile of pancreatic intraepithelial neoplasia[J].Mod Pathol,2008,21(3):238-244.
|
|
[10] SATO N,FUKUSHIMA N,MAITRA A,et al. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays[J]. Cancer Res,2003,63(13):3735-3742.
|
|
[11] GINESTMM,MORA J,MAYOR R,et al. Genetic and epigenetic markers in the evaluation of pancreatic masses[J]. J Clin Pathol,2013,66(3):192-197.
|
|
[12] YANG WH,WANG CY,ZHU QS. p16 gene methylation and its protein expression in pancreatic carcinoma[J]. J Clin Surg,2007,15(7):454-456.(in Chinese)杨卫华，王春友，朱求实，等．胰腺癌中p16基因甲基化改变及其蛋白表达分析[J]．临床外科杂志，2007,15(7):454-456.
|
|
[13] PARSI MA,LI A,LI CP,et al. DNA methylation alterations in endoscopic retrograde cholangiopancreatography brush samples of patients with suspected pancreaticobiliary disease[J].Clin Gastroenterol Hepatol,2008,6(11):1270-1278.
|
|
[14] PARK JK,RYU JK,LEE KH,et al. Quantitative analysis of NPTX2 hypermethylation is a promising molecular diagnostic marker for pancreatic cancer[J]. Pancreas,2007,35(3):e9-e15.
|
|
[15] YOKOYAMA S,HIGASHI M,KITAMOTO S,et al. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas[J].Oncotarget,2016,7(27):42553-42565.
|
|
[16] ZHU Y,ZHANG JJ,ZHU R,et al. The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma[J]. Med Oncol,2011,28(Suppl 1):s175-s184.
|
|
[17] VINCENT A,DUCOUROUBLE MP,VAN SI. Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases[J]. FASEB J,2008,22(8):3035-3045.
|
|
[18] YAMADA N,NISHIDA Y,TSUTSUMIDA H,et al. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4[J]. Br J Cancer,2009,100(2):344-351.
|
|
[19] SATO N,MAEHARA N,SU GH,et al. Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness[J]. J Natl Cancer Inst,2003,95(4):327-330.
|
|
[20] TOMCZAK K,CZERWINSKA P,WIZNEROWICZ M. The Cancer Genome Atlas(TCGA):An immeasurable source of knowledge[J]. Contemp Oncol(Pozn),2015,19(1A):a68-a77.
|
|
[21] Cancer Genome Atlas Research Network,WEINSTEIN JN,COLLISSON EA,et al. The Cancer Genome Atlas Pan-Cancer analysis project[J]. Nat Genet,2013,45(10):1113-1120.
|
|
[22] ZHANG J,BARAN J,CROS A,et al. International cancer genome consortium data portal-a one-stop shop for cancer genomics data[J]. Database(Oxford), 2011, 2011:bar026.
|
|
[23] KISIEL JB,YAB TC,TAYLOR WR,et al. Stool DNA testing for the detection of pancreatic cancer:Assessment of methylation marker candidates[J]. Cancer,2012,118(10):2623-2631.
|
|
[24] THOMPSON MJ,RUBBI L,DAWSON DW,et al. Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes[J]. PLo S One,2015,10(6):e0128814.
|
|
[25] KISIEL JB,RAIMONDO M,TAYLOR WR,et al. New DNA methylation markers for pancreatic cancer:Discovery,tissue validation,and pilot testing in pancreatic juice[J]. Clin Cancer Res,2015,21(19):4473-4481.
|
|
[26] NEALE RE,CLARK PJ,FAWCETT J,et al. Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer[J]. Cancer Epidemiol,2014,38(5):576-582.
|
|
[27] GINESTA MM,DIAZ-RIASCOS ZV,BUSQUETS J,et al.APC promoter is frequently methylated in pancreatic juice of patients with pancreatic carcinomas or periampullary tumors[J]. Oncol Lett,2016,12(3):2210-2216.
|
|
[28] YOKOYAMA S,KITAMOTO S,HIGASHI M,et al. Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice[J]. PLo S One,2014,9(4):e93760.
|
|
[29] MATSUBAYASHI H,CANTO M,SATO N,et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease[J]. Cancer Res,2006,66(2):1208-1217.
|
|
[30] MATSUBAYASHI H,SATO N,FUKUSHIMA N,et al. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues[J]. Clin Cancer Res,2003,9(4):1446-1452.
|
|
[31] YAO F,SUN M,DONG M,et al. NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms[J]. Am J Med Sci,2013,346(3):175-180.
|
|
[32] NISHIZAWA N,HARADA H,KUMAMOTO Y,et al. Diagnostic potential of hypermethylation of the cysteine dioxygenase 1gene(CDO1)promoter DNA in pancreatic cancer[J]. Cancer Sci,2019,110(9):2846-2855.
|
|
[33] YACHIDA S,JONES S,BOZIC I,et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer[J].Nature,2010,467(7319):1114-1117.
|
DownLoad: